IRIS
CORRADO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.374
EU - Europa 3.126
AS - Asia 1.058
SA - Sud America 8
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 7.575
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.351
IE - Irlanda 877
SE - Svezia 803
CN - Cina 550
SG - Singapore 420
IT - Italia 323
UA - Ucraina 277
DE - Germania 233
PL - Polonia 178
FI - Finlandia 142
GB - Regno Unito 114
FR - Francia 80
BE - Belgio 46
IN - India 46
CA - Canada 19
RU - Federazione Russa 18
VN - Vietnam 12
NL - Olanda 9
CZ - Repubblica Ceca 6
ID - Indonesia 6
ES - Italia 5
IR - Iran 5
AU - Australia 4
BR - Brasile 4
JP - Giappone 4
RO - Romania 4
EC - Ecuador 3
IL - Israele 3
LU - Lussemburgo 3
AT - Austria 2
BD - Bangladesh 2
CR - Costa Rica 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
KH - Cambogia 1
KR - Corea 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 7.575
Salva come PNG Salva come JPEG
Città #
Dublin 876
Chandler 643
Jacksonville 574
Nyköping 431
Singapore 355
Beijing 225
Ashburn 221
Warsaw 170
Boardman 160
Ann Arbor 157
Princeton 129
Cambridge 127
Messina 114
Medford 110
Dearborn 106
Des Moines 99
Woodbridge 61
Brussels 46
Shenyang 40
Jinan 39
Wilmington 36
Bremen 35
Catania 33
Los Angeles 33
Hyderabad 28
Hebei 25
Lancaster 25
Nanjing 24
Zhengzhou 24
Helsinki 22
San Mateo 21
Washington 20
Tianjin 18
Houston 16
New York 16
Ningbo 15
Seattle 15
Haikou 14
Munich 14
Hangzhou 13
Auburn Hills 12
Dong Ket 12
Taizhou 12
Ottawa 11
London 10
Pune 10
Nanchang 9
Milan 8
Viagrande 8
Augusta 7
Changsha 7
Guangzhou 7
Norwalk 7
Jakarta 6
Jiaxing 6
Lanzhou 6
Turin 6
Clearwater 5
Falls Church 5
Hefei 5
Leawood 5
Ardabil 4
Kraków 4
Mountain View 4
Poznan 4
Toronto 4
Trecastagni 4
Amsterdam 3
Brno 3
Cagliari 3
Edinburgh 3
Fuzhou 3
Las Vegas 3
Luxembourg 3
Mumbai 3
Novokuznetsk 3
Paterno 3
Phoenix 3
Polverigi 3
Quito 3
Rho 3
Saint Petersburg 3
Shanghai 3
Taiyuan 3
Xi'an 3
Andover 2
Boston 2
Cairo Montenotte 2
Caltagirone 2
Frankfurt am Main 2
Greifswald 2
Hong Kong 2
Jeffries 2
Lentini 2
Mascalucia 2
Monterotondo 2
New Delhi 2
Newark 2
Palermo 2
Prague 2
Totale 5.402
Salva come PNG Salva come JPEG
Nome #
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 115
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 110
Italian risk factor-based screening for gestational diabetes. 106
Effects of myo-inositol on glucose variability in women with gestational diabetes 90
Screening for gestational diabetes in Sicily. 89
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 88
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 88
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 85
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 85
Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis 82
A 45,X MALE WITH MOLECULAR EVIDENCE OF A TRANSLOCATION OF Y- EUCHROMATIN ONTO CHROMOSOME-1 81
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 81
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 81
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 81
Intravaginal vs. intracervical PGE(2) gel first application for labor induction 80
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 80
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 80
Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus 78
Compliance with hormone replacement therapy in postmenopausal Sicilian women 77
Glucose Tolerance and insulin secretion in pregnancy 75
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 75
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 75
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 74
Abortività spontanea ed età materna avanzata. 74
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 74
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 71
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 71
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 70
A 45,MALE WITH MOLECULAR EVIDENCE OF A TRANSLOCATION OF Y EUCHROMATIN ONTO CHROMOSOME 1 70
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 68
Role of urocortin in pregnancy: an update and future perspectives 68
Celiac disease in pregnancy: not always a relapse 67
"Anticorpi antifosfolipidi ed aborto ricorrente". 67
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 67
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 66
PREGNANCY IN ESSENTIAL THROMBOCYTHEMIA DURING ASPIRIN TREATMENT 64
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 64
Myo-inositol may prevent gestational diabetes in PCOS women 64
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 64
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 63
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 63
Cardiovascular effects of the phytoestrogen genistein 63
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 63
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 63
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 63
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 63
Rupture of the cervix in a sulprostone induced abortion in the second trimester 62
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 62
VARIABILITA' GENOTIPICA E FENOTIPICA DELLA SINDROME DI PATAU.. OSSERVAZIONE DI UN CASO 62
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 62
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 62
Cardiovascular effects of raloxifene hydrochloride 62
Differences in body composition between post-menopausal women with and without dyslipidemia. 62
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 62
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 62
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 61
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 61
Diagnosis of gestational diabetes mellitus: italian perspectives on risk factor based screening 61
Prostate-specific antigen in prenatal screening for Down's syndrome 60
Diagnosis of celiac disease in pregnancy and puerperium: think about it 59
C-reactive protein as an early predictor of gestational diabetes mellitus 59
Midtrimester amniotic fluid adiponectin in normal pregnancy. 59
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 58
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 58
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 57
Gestational glucose intolerance multiple pregnancy 57
Screening for gestational diabetes in Sicily 57
Modalità di prelievo in corso d'amniocentesi ed outcome ostetrico 57
Neurokinin B peptide levels in normal pregnancy 56
Large placental chorioangioma 56
A randomised trial of progesterone prophylaxis after midtrimester amniocentesis 56
Prenatally identified Pallister-Killian syndrome: Ultrasound pattern and diagnostic considerations 56
Intraperitoneal chemotherapy with mitoxanthrone in ovarian cancer 55
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 55
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 55
Intolleranza glucidica e disordini ipertensivi in gravidanza. 55
Sindrome mano-piede-utero. Descrizione di un caso ad ereditarietà autosomica recessiva. 54
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 54
La disfunzione diastolica nel diabete gestazionale 54
How to achieve high-quality oocytes? The key role of myo-Inositol and melatonin 54
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 53
Maternal serum PAPP-A as an early marker of obstetric complications? 53
Predittività dell’OGTT sugli outcomes clinici ed ostetrici nella ridotta tolleranza glucidica in gravidanza 52
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 52
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 52
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 51
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 51
I LIVELLI SIERICI DI NGAL NEL PRIMO TRIMESTRE DELLA GRAVIDANZA SONO PREDITTIVI DELL’INSORGENZA DI DIABETE GESTAZIONALE. 51
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 51
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 51
SULLA MUTAGENICITA' DEL METRONIDAZOLO 50
First trimester serum PAPP-A and NGAL in the prediction of late-onset preeclampsia 50
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 50
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 50
Gestational weight gain across continents and ethnicity: Systematic review and meta-analysis of maternal and infant outcomes in more than one million women 50
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 49
VALUTAZIONE LONGITUDINALE DI DONNE CON RIDOTTA TOLLERANZA GLUCIDICA IN GRAVIDANZA 49
Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction 48
The placental growth hormone in Down's syndrome screening 48
TESTICULAR REGRESSION SYNDROME - A CASE-REPORT 48
Totale 6.477
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.528
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020701 0 0 0 0 0 0 144 124 45 175 182 31
2020/2021981 113 36 200 45 64 105 56 98 45 109 72 38
2021/2022979 11 155 18 28 35 11 60 37 24 239 105 256
2022/20232.621 181 260 140 171 218 263 15 155 1.094 15 82 27
2023/2024703 54 96 46 97 64 113 16 21 7 46 7 136
2024/2025571 44 34 52 196 127 114 4 0 0 0 0 0
Totale 7.760